Newsletter Archive

  1. 10.15.26 -- New Advances In Drug Safety With Human-Relevant Preclinical Models 10/15/2026

    10/15/26 Drug Discovery Online Newsletter

  2. 10.15.26 -- Research Partners And Solutions For Drug Discovery's Toughest Challenges 10/15/2026
    10/15/26 Drug Discovery Online Newsletter
  3. 10.13.26 -- Bravo, FDA For Retiring 'Animal Testing' In Favor Of 'Nonclinical' 10/13/2026

    10/13/26 Drug Discovery Online Newsletter

  4. 10.08.26 -- Streamline Lead Selection & Optimization For Cell Therapy Development 10/8/2026

    10/08/26 Drug Discovery Online Newsletter

  5. 10.06.26 -- Datapoints Summit 2026 Highlights: Moving AI Closer To The Lab 10/6/2026

    10/06/26 Drug Discovery Online Newsletter

  6. 10.03.26 -- Drug Discovery Online Best Of September 10/3/2026

    10/03/26 Drug Discovery Online Newsletter

  7. 09.29.26 -- What I Heard When NAMs Became A Conversation, Not A Webinar 9/29/2026

    09/29/26 Drug Discovery Online Newsletter

  8. 09.22.26 -- 2026 Nucleate Boston Activator Cohort Interview: Michael Cronce — Omni Therapeutics 9/22/2026

    09/22/26 Drug Discovery Online Newsletter

  9. 09.16.26 -- Smarter Ways To Reduce Risk, Downtime, And Lifecycle Surprises 9/16/2026

    09/16/26 Drug Discovery Online Newsletter

  10. 09.15.26 -- A Simple Eye Drop For A Blinding Disease? Claris Bio Raises $118M And Prepares For Pivotal Trials 9/15/2026

    09/15/26 Drug Discovery Online Newsletter